Investment Opportunity

Pioneering Electron Delivery Technology for Human Health

Currently in stealth mode with prototype validation underway

The Opportunity

Grounded Ventures is developing breakthrough technology designed to address oxidative stress—a fundamental health challenge affecting billions globally.

Our approach leverages cutting-edge electron systems offering a passive, continuous solution that requires no lifestyle changes or active user intervention.


Market Validation

Endorsed by Space Health Leaders

“As an astronaut, I understand the toll that extreme environments take on the body. OxSHIELD presents a promising innovation in wearable tech aimed at mitigating oxidative stress—something I believe could have a meaningful impact both in space and here on Earth.”

— Nicole Stott, NASA Astronaut (Retired)

The Translational Research Institute for Space Health (TRISH) has expressed interest in OxSHIELD for potential future missions—highlighting its alignment with NASA’s focus on astronaut health and next-generation space medicine.

— Dr. Dorit Donoviel, Director, NASA TRISH

Large, Growing Markets

  • Multi-billion dollar addressable market across wellness, defense, and aerospace
  • Rising demand for passive health technologies
  • Limited effective solutions currently available

Development Stage

Current Phase: Prototype validation and safety testing
Next Milestone: Clinical validation studies
Business Model: Strategic licensing partnerships

We are taking a methodical, science-first approach to ensure our technology meets the highest standards for safety and efficacy.


Funding

We are currently raising a pre-seed round to fund:

  • Prototype validation studies
  • Clinical testing and biomarker analysis
  • Core team expansion
  • IP development

Investment Range: Available upon qualified inquiry
Timeline: 3-9 month validation runway


Investor Qualification

This opportunity is available only to accredited investors. Due to our stealth status, detailed technical and financial information is shared only with qualified prospects under appropriate confidentiality agreements.

Name